Nvidia Is Driving A 70% Cost Crash In Drug Discovery — Lilly Just Bet $1 Billion On It

The cost of drug discovery has always been time. Nvidia Corp (NASDAQ:NVDA) says it just crushed that cost by 70% — and Eli Lilly And Co (NYSE:LLY) just put $1 billion behind the claim.At JPMorgan's healthcare conference, Nvidia wasn't pitching AI as a helper in the lab. It was pitching AI as a replacement for the slowest, costliest part of drug discovery: human-paced iteration. Remove that bottleneck, Nvidia argues, and costs don't inch lower — they collapse, by as much as 70%.The Cost Was Never The Science ...